12 Followers on Owler
OverviewCompetitorsNews & Insights

Orexo Competitors or Alternatives

Orexo's top competitors include NeuroVive, BioInvent and Karo Bio.

Unlock 15 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Orexo's company profile

Nikolaj Sorensen

President & CEO

68/100
118
$0
$63.3M
  • $0
    $63.3M
  • 118
    $0
  • $63.3M
  • 68/100
  • 118
  • $0
  • $63.3M
View ProfileView
1
Orexo's Competitor - NeuroVive logo

Erik Kinnman

CEO

88/100
9
$3.2M
$ < 1M
  • $3.2M
    $ < 1M
  • 9
    $3.2M
  • $ < 1M
  • 88/100
  • 9
  • $3.2M
  • $ < 1M
View ProfileView
2
Orexo's Competitor - BioInvent logo

Martin Welschof

President & CEO

92/100
93
$34.5M
$30.4M
  • $34.5M
    $30.4M
  • 93
    $34.5M
  • $30.4M
  • 92/100
  • 93
  • $34.5M
  • $30.4M
View ProfileView
3
Orexo's Competitor - Karo Bio logo

Maria Sjoberg

President & CEO

68/100
39
$30M
$3.8M
  • $30M
    $3.8M
  • 39
    $30M
  • $3.8M
  • 68/100
  • 39
  • $30M
  • $3.8M
View ProfileView
4
Orexo's Competitor - GENFIT logo

Pascal Prigent

CEO

87/100
150
$533.1M
$42.1M
  • $533.1M
    $42.1M
  • 150
    $533.1M
  • $42.1M
  • 87/100
  • 150
  • $533.1M
  • $42.1M
View ProfileView
5
Orexo's Competitor - Phenex logo

Claus Kremoser

Co-Founder & CEO

88/100
25 - 100
$13.5M
$25M - 100M
  • $13.5M
    $25M - 100M
  • 25 - 100
    $13.5M
  • $25M - 100M
  • 88/100
  • 25 - 100
  • $13.5M
  • $25M - 100M
View ProfileView
Orexo's top 18 competitors are NeuroVive, BioInvent, Karo Bio, Active Biotech, GENFIT, Phenex, Allenex AB, BDSI, Mitobridge, Indivior, Stealth, Pfizer, Moberg Pharma, MSDC, Novartis, Amgen, Mission Therapeutics and AstraZeneca. Together they have raised over 6.4B between their estimated 276.0K employees. Orexo has 118 employees and is ranked 8th among it's top 10 competitors. The top 10 competitors average 14,530.

Orexo VS NeuroVive

NeuroVive is seen as one of Orexo's top competitors. NeuroVive was founded in 1998, and is headquartered in Lund, Skåne län. Like Orexo, NeuroVive also competes in the Pharmaceuticals industry. NeuroVive generates $63.3M less revenue vs. Orexo.

Orexo VS BioInvent

BioInvent is a top competitor of Orexo. BioInvent was founded in 1996, and its headquarters is in Lund, Skåne län. Like Orexo, BioInvent also competes in the Pharmaceuticals & Biotechnology field. BioInvent has 25 fewer employees than Orexo.

Looking for similar companies to Orexo?

Similar Companies

Pharmaceuticals companies in Uppsala

See 13 companies 
Companies in Uppsala with employees in 100-250 range

See 14 companies 
Companies in Uppsala with revenue in $25-100M range

See 16 companies 
Companies in Uppsala län with employees in 100-250 range

See 15 companies 
Pharmaceuticals & Biotechnology companies in Uppsala län

See 16 companies 
Companies in Uppsala län with revenue in $25-100M range

See 18 companies 
Pharmaceuticals & Biotechnology companies in Uppsala

See 24 companies 
Pharmaceuticals companies in Sweden

See 213 companies 
Pharmaceuticals & Biotechnology companies in Sweden

See 477 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Orexo and Orexo's Competitors

April 29, 2025FinanzNachrichten
LUND, SE / ACCESS Newswire / April 29, 2025 / BioInvent International (STO:BINV)"The first quarter of 2025 was a highly productive period across clinic...
April 29, 2025Benzinga
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 29, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutica...
April 30, 2025Medthority
The trial met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a clinically meaningful and statistically sig...
April 30, 2025Endpoints News
Novartis plans to acquire Regulus Therapeutics for $7.00 per share in cash, or $800 million, the microRNA specialist said Wednesday. This is more than ...
April 29, 2025Marketscreener
CAMBRIDGE , Britain (AP) - CAMBRIDGE , Britain (AP) - Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion . On a per-share ...
April 29, 2025StreetInsider
- FDA decision on elamipretide for the treatment of Barth syndrome delayed -- Labelling discussions underway, but no revised action date communicated b...
April 29, 2025NewYork Post
The new facility will produce biologic drugs and Keytruda, becoming Merck's first in-house US site to make the blockbuster cancer treatment, the compan...
April 30, 2025Nasdaq
Eli Lilly (NYSE:LLY) is scheduled to release its earnings report on Thursday, May 1, 2025. For event-driven traders, historical stock performance follo...
April 29, 2025Zacks
Volume growth of AMGN's key drugs like Evenity, Repatha and Kyprolis is expected to have been partially offset by biosimilar/generic competition for ma...
April 29, 2025FinanzNachrichten
LUND, SWEDEN / ACCESS Newswire / April 29, 2025 / The Annual General Meeting ("AGM") of BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV...

Frequently Asked Questions about Orexo

  1. Who are Orexo's top competitors?

    Orexo's top 3 competitors are NeuroVive, BioInvent, Karo Bio.

  2. Who is similar to Orexo?

    NeuroVive is the most similar to Orexo. BioInvent and Karo Bio are also similar to Orexo.

  1. Are Orexo and NeuroVive competitors?

    Yes, NeuroVive is one of Orexo’s top competitors.